CNS pipeline · person
Ludwig Hantson, PhD
Director of Ionis Pharmaceuticals appointed effective June 4, 2026. A veteran biopharmaceutical executive with more than 30 years of leadership experience, he served as Chief Executive Officer and a board member of Alexion from 2017 to 2021, prior to its acquisition by AstraZeneca, and earlier held senior roles at Baxter, Novartis and Johnson & Johnson.
- 1 company
Current roles
- Ionis Pharmaceuticals, Inc.Director · Board2026–present
Appears with
People sharing a company with Ludwig.
- Allene M. Diaz · Ionis Pharmaceuticals, Inc.
- Brett P. Monia · Ionis Pharmaceuticals, Inc.
- Brian Birchler · Ionis Pharmaceuticals, Inc.
- C. Frank Bennett · Ionis Pharmaceuticals, Inc.
- Elizabeth L. Hougen · Ionis Pharmaceuticals, Inc.
- Eric E. Swayze · Ionis Pharmaceuticals, Inc.
- Eugene Schneider · Ionis Pharmaceuticals, Inc.
- Holly Kordasiewicz · Ionis Pharmaceuticals, Inc.
- Joan E. Herman · Ionis Pharmaceuticals, Inc.
- Joseph Klein, III · Ionis Pharmaceuticals, Inc.
- Joseph Loscalzo · Ionis Pharmaceuticals, Inc.
- Joseph T. Baroldi · Ionis Pharmaceuticals, Inc.
- Kyle Jenne · Ionis Pharmaceuticals, Inc.
- Michael Hayden · Ionis Pharmaceuticals, Inc.
- Michael Yang · Ionis Pharmaceuticals, Inc.
- Patrick R. O'Neil · Ionis Pharmaceuticals, Inc.
- Peter N. Reikes · Ionis Pharmaceuticals, Inc.
- Shannon L. Devers · Ionis Pharmaceuticals, Inc.
- Spencer R. Berthelsen · Ionis Pharmaceuticals, Inc.
- Stanley T. Crooke · Ionis Pharmaceuticals, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.